MINNEAPOLIS, July 23, 2015 /PRNewswire/ -- Verde Technologies announced that its Deterra Drug Deactivation System, the first tool that is scientifically tested to safely and effectively neutralize and dispose of leftover prescription medications in a self-contained pouch, will debut to pharmacists attending the Cardinal Health Retail Business Conference (RBC) from July 22 – 25 in Las Vegas. RBC is one of the largest gatherings of independent pharmacists. The Deterra System will be demonstrated and available for sale at booth #4850.
The Deterra System is the first and only solution that utilizes patented MAT12™ Molecular Adsorption Technology to deactivate unwanted, unneeded opioids, antibiotics, transdermal patches and other prescription drugs, rendering them ineffective for misuse and safe for the environment. The Deterra System features a pouch containing MAT12, a proprietary activated carbon that bonds to pharmaceutical compounds when water is added, rendering drugs ineffective and safe for disposal quickly in any setting – pharmacy, home, clinic or hospital.
"Cardinal Health is an outstanding leader in healthcare services, and we're excited to offer Deterra to their pharmacist partners during the RBC event," said Jason Sundby, president and CEO of Verde Technologies. "Using Deterra to neutralize and safely dispose of drugs will not only help to reduce prescription drug abuse but will also reduce negative impact on the environment."
Deterra has a 98.1 percent success rate in deactivating prescription drugs, according to a research study supported by the National Institute on Drug Abuse (NIDA). Designed to be a cost-effective and easy-to-use drug abuse deterrent, Deterra is also environmentally friendly as it renders chemical compounds safe for landfills. It also provides an excellent alternative to take back incineration programs and potentially reduces watershed contamination.
To learn more or purchase Deterra during the RBC event, visit booth #4850. For more information on Deterra, visit www.DeterraSystem.com. For more information on the RBC event, visit www.CardinalHealth.com/RBC.
About Verde Technologies
Minneapolis-based Verde Technologies is a privately-owned company committed to developing research-based, scientifically proven solutions to reduce drug abuse, misuse and negative environmental impact. The Deterra Drug Deactivation System is powered by patented MAT12 Molecular Adsorption Technology, which deactivates prescription drugs using proprietary activated carbon. The technology is highly effective in adsorbing and firmly binding pharmaceuticals, rendering them inactive and ineffective for misuse and safe for the environment. For more information or to order, please visit www.DeterraSystem.com or follow @deterrasystem on Twitter.
About the Cardinal Health Retail Business Conference (RBC)
The Cardinal Health Retail Business Conference (RBC), held July 22-25 in Las Vegas, provides independent pharmacists and pharmacy franchise owners with the opportunity to network with and learn from thousands of their peers from across the nation, while gaining new insights to improve the effectiveness and efficiency of their businesses. The annual event provides independent pharmacy owners, pharmacists, pharmacy technicians and other pharmacy industry professionals across the United States with access to pharmaceutical manufacturers, buying opportunities, continuing education sessions and programs to help pharmacists reduce costs and improve patient care and efficiency. For more information, visit www.CardinalHealth.com/RBC or use #RBCWin on Twitter.
SOURCE Verde Technologies